Nancy Crotti, Managing Editor and Danielle Kirsh, Senior Editor
Amid the stock market roller-coaster ride that began last month, medtech companies that make devices and diagnostic tests vital to fighting COVID-19 may ultimately fare better than others, but it’s hard to tell until the virus peaks and people get back to work.
At midafternoon today, the Medical Design & Outsourcing Medtech 100 Index was down 21.8% from its close at $91.92 on Feb. 19, the day before the stock market crashed. (The Medtech 100 Index is our new financial index calculated using the Big 100 companies covered in Medical Design and Outsourcing.)